(The Center Square) – Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner, Marty Makary, accountable for leaving its promise to review the “dangerous” abortion drug ...

Presented by the Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care PRESENTED BY COALITION TO ...

The Ethics & Public Police Center study found that about 11% of women experience sepsis, infection, hemorrhaging, or another ...

Hawley and other anti-abortion groups and legislators say the health organization is "slow-walking" a review of the drug ...

Food and Drug Administrator Marty Makary says he has a "moral duty" to inform the public of the risks of the COVID-19 vaccine ...

Marjorie Dannenfelser called for FDA Commissioner Marty Makary to be fired for allegedly delaying a mifepristone safety ...

The move comes after the FDA quietly approved a new generic version of the abortion drug mifepristone in October.

The White House says it has the "utmost confidence" in Food and Drug Administration Commissioner Marty Makary as pro-life ...

The White House said Tuesday it has the “utmost confidence” in Food and Drug Administration (FDA) Commissioner Mary Makary ...

Dec 8 (Reuters) - The U.S. Food and Drug Administration has delayed a review of safety data for the abortion drug ...

In her nine months as scientific adviser to U.S. Food and Drug Administration Commissioner Marty Makary, Tracy Beth Høeg’s ...

Drugs for high cholesterol and migraine could become OTC in the U.S. But without a comprehensive behind-the-counter ...